Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Health Care Sector · Voya

DLHCX Holdings: What Nomura Healthcare Fund Owns

Ticker DLHCX · · Holdings as of Jun 30, 2026

Expense ratio
1.96%$196/yr per $10k
5-yr return
+6.7%annualized
1-yr return
+20.2%as of Dec 2025
Net assets
$750.2Mall share classes
Holdings
108

Bottom line

What does DLHCX hold?

DLHCX held 108 positions as of Jun 30, 2026. Its largest holding is Ucb Sa at 5.19% of the fund, and the top 10 positions add up to 38.9%. By asset type it is 95% stocks, 3% preferred stock, 2% cash & short-term funds.

Updated Aug 26, 2026

DLHCX top 25 holdings

#HoldingType% of fundValue
1 Ucb Sa UCB
UCB SA NPV
Stocks 5.19%$39.0M
2 Abbvie Inc ABBV
ABBVIE INC COM
Stocks 4.19%$31.5M
3 Eli Lilly & Company LLY
ELI LILLY & COMPANY COM
Stocks 4.16%$31.2M
4 Regeneron Pharmaceuticals Inc REGN
REGENERON PHARMACEUTICALS INC COM
Stocks 3.91%$29.3M
5 Unitedhealth Group Inc UNH
UNITEDHEALTH GROUP INC COM
Stocks 3.88%$29.1M
6 Pfizer Inc PFE
PFIZER INC COM
Stocks 3.84%$28.8M
7 Merck & Company Inc MRK
MERCK & COMPANY INC COM
Stocks 3.68%$27.6M
8 Gilead Sciences Inc GILD
GILEAD SCIENCES INC COM
Stocks 3.54%$26.5M
9 Astrazeneca Plc AZN
ASTRAZENECA PLC ORD USD0.25
Stocks 3.27%$24.5M
10 Elevance Health Inc ELV
ELEVANCE HEALTH INC COM
Stocks 3.25%$24.4M
11 Roche Holding Ag ROP
ROCHE HOLDING AG CHF0.001
Preferred stock 3.01%$22.6M
12 Chugai Pharmaceutical Co Ltd 4519
CHUGAI PHARMACEUTICAL CO LTD NPV
Stocks 2.77%$20.8M
13 Viatris Inc VTRS
VIATRIS INC COM
Stocks 2.48%$18.6M
14 Oruka Therapeutics Inc ORKA
ORUKA THERAPEUTICS INC COM
Stocks 2.41%$18.1M
15 Halozyme Therapeutics Inc HALO
HALOZYME THERAPEUTICS INC COM
Stocks 2.30%$17.2M
16 Amgen Inc AMGN
AMGEN INC COM
Stocks 2.27%$17.0M
17 Illumina Inc ILMN
ILLUMINA INC COM
Stocks 2.11%$15.8M
18 Alkermes Plc ALKS
ALKERMES PLC COM USD0.01
Stocks 1.82%$13.6M
19 Viking Therapeutics Inc VKTX
VIKING THERAPEUTICS INC COM
Stocks 1.72%$12.9M
20 Vertex Pharmaceuticals Inc VRTX
VERTEX PHARMACEUTICALS INC COM
Stocks 1.66%$12.4M
21 Roivant Sciences Ltd ROIV
ROIVANT SCIENCES LTD SHS
Stocks 1.60%$12.0M
22 Neurocrine Biosciences Inc NBIX
NEUROCRINE BIOSCIENCES INC COM
Stocks 1.57%$11.8M
23 Arcus Biosciences Inc RCUS
ARCUS BIOSCIENCES INC COM
Stocks 1.56%$11.7M
24 Zimmer Biomet Holdings Inc ZBH
ZIMMER BIOMET HOLDINGS INC COM
Stocks 1.42%$10.7M
25 Boston Scientific Corp BSX
BOSTON SCIENTIFIC CORP COM
Stocks 1.42%$10.7M

Source: SEC Form N-PORT, period ended Jun 30, 2026, filed Aug 26, 2026

Asset mix

Stocks94.8%
Preferred stock3.0%
Cash & short-term funds2.0%

Country exposure

BE5.2%
BM1.6%
CH3.0%
DE0.2%
FR2.0%
GB3.3%
IE3.2%
IL0.3%
JP2.8%
KY1.2%